Publications
-
18F-FDG PET/CT Demonstration of Diffuse Lymphohistiocytic Granulomatous Vasculitis.
Kumar M,
Iagaru A.
Clin Nucl Med.
2013
-
Combined 18F-fluoride and 18F-FDG PET/CT scanning for evaluation of malignancy: results of an international multicenter trial.
Iagaru A,
Mittra E, Mosci C, Dick DW, Sathekge M, Prakash V, Iyer V, Lapa P, Isidoro J, de Lima JM, Gambhir SS.
J Nucl Med.
2013;
54
(2):
176-83
-
Pilot Prospective Evaluation of 99mTc-MDP Scintigraphy, 18F NaF PET/CT, 18F FDG PET/CT and Whole-Body MRI for Detection of Skeletal Metastases.
Iagaru A,
Young P, Mittra E, Dick DW, Herfkens R, Gambhir SS.
Clin Nucl Med.
2013
-
Root Cause Analysis of Gastroduodenal Ulceration After Yttrium-90 Radioembolization.
Lam MG,
Banerjee S, Louie JD, Abdelmaksoud MH, Iagaru AH, Ennen RE, Sze DY.
Cardiovasc Intervent Radiol.
2013
-
Safety of Repeated Yttrium-90 Radioembolization.
Lam MG,
Louie JD, Iagaru AH, Goris ML, Sze DY.
Cardiovasc Intervent Radiol.
2013
-
Second Sino-American Conference on Nuclear Medicine.
Delbeke D,
Alessio A, Iagaru A.
J Nucl Med.
2013;
54
(4):
15N-6N
-
18F-FDG PET/CT demonstration of a liver metastasis in a patient with papillary thyroid cancer.
Mosci C,
McDougall IR, Jeffrey RB, Iagaru A.
Clin Nucl Med.
2012;
37
(9):
e234-6
-
Demonstration of peripheral nerve root involvement by non-Hodgkin's lymphoma on 18F-FDG PET/CT.
Guo H,
Mosci C, Iagaru A.
Eur J Nucl Med Mol Imaging.
2012;
39
(4):
729-30
-
Initial investigation of ¹⁸F-NaF PET/CT for identification of vertebral sites amenable to surgical revision after spinal fusion surgery.
Quon A,
Dodd R, Iagaru A, de Abreu MR, Hennemann S, Neto JM, Sprinz C.
Eur J Nucl Med Mol Imaging.
2012;
39
(11):
1737-44
-
Positron emission tomography of 64Cu-DOTA-Rituximab in a transgenic mouse model expressing human CD20 for clinical translation to image NHL.
Natarajan A,
Gowrishankar G, Nielsen CH, Wang S, Iagaru A, Goris ML, Gambhir SS.
Mol Imaging Biol.
2012;
14
(5):
608-16
-
Prognostic value of metabolic tumor volume and velocity in predicting head-and-neck cancer outcomes.
Chu KP,
Murphy JD, La TH, Krakow TE, Iagaru A, Graves EE, Hsu A, Maxim PG, Loo B, Chang DT, Le QT.
Int J Radiat Oncol Biol Phys.
2012;
83
(5):
1521-7
-
Prospective comparison of combined 18F-FDG and 18F-NaF PET/CT vs. 18F-FDG PET/CT imaging for detection of malignancy.
Lin FI,
Rao JE, Mittra ES, Nallapareddy K, Chengapa A, Dick DW, Gambhir SS, Iagaru A.
Eur J Nucl Med Mol Imaging.
2012;
39
(2):
262-70
-
Prospective evaluation of (99m)Tc MDP scintigraphy, (18)F NaF PET/CT, and (18)F FDG PET/CT for detection of skeletal metastases.
Iagaru A,
Mittra E, Dick DW, Gambhir SS.
Mol Imaging Biol.
2012;
14
(2):
252-9
-
Response to intra-arterial oncolytic virotherapy with the herpes virus NV1020 evaluated by [18F]fluorodeoxyglucose positron emission tomography and computed tomography.
Sze DY,
Iagaru AH, Gambhir SS, De Haan HA, Reid TR.
Hum Gene Ther.
2012;
23
(1):
91-7
-
Validation that metabolic tumor volume predicts outcome in head-and-neck cancer.
Tang C,
Murphy JD, Khong B, La TH, Kong C, Fischbein NJ, Colevas AD, Iagaru AH, Graves EE, Loo BW, Le QT.
Int J Radiat Oncol Biol Phys.
2012;
83
(5):
1514-20
-
(18)F-FDG PET/CT: timing for evaluation of response to therapy remains a clinical challenge.
Iagaru A,
Am J Nucl Med Mol Imaging.
2011;
1
(1):
63-4
-
Case 166: Metastatic left pulmonary artery sarcoma.
Mittra ES,
Iagaru AH, Leung AN.
Radiology.
2011;
258
(2):
645-8
-
Correlation between metabolic tumor volume and pathologic tumor volume in squamous cell carcinoma of the oral cavity.
Murphy JD,
Chisholm KM, Daly ME, Wiegner EA, Truong D, Iagaru A, Maxim PG, Loo BW, Graves EE, Kaplan MJ, Kong C, Le QT.
Radiother Oncol.
2011;
101
(3):
356-61
-
FDG-PET/CT in cancers of the head and neck: what is the definition of whole body scanning?
Iagaru A,
Mittra ES, Gambhir SS.
Mol Imaging Biol.
2011;
13
(2):
362-7
-
PET/CT imaging of thyroid cancer.
Mosci C,
Iagaru A.
Clin Nucl Med.
2011;
36
(12):
e180-5
-
Pilot pharmacokinetic and dosimetric studies of (18)F-FPPRGD2: a PET radiopharmaceutical agent for imaging α(v)β(3) integrin levels.
Mittra ES,
Goris ML, Iagaru AH, Kardan A, Burton L, Berganos R, Chang E, Liu S, Shen B, Chin FT, Chen X, Gambhir SS.
Radiology.
2011;
260
(1):
182-91
-
Thyroid stunning: fact or fiction?
McDougall IR,
Iagaru A.
Semin Nucl Med.
2011;
41
(2):
105-12
-
131I-Tositumomab (Bexxar) vs. 90Y-Ibritumomab (Zevalin) therapy of low-grade refractory/relapsed non-Hodgkin lymphoma.
Iagaru A,
Mittra ES, Ganjoo K, Knox SJ, Goris ML.
Mol Imaging Biol.
2010;
12
(2):
198-203
-
Case 166.
Mittra ES,
Iagaru AH, Leung AN.
Radiology.
2010;
257
(1):
288-9
-
Current concepts and future directions in radioimmunotherapy.
Lin FI,
Iagaru A.
Curr Drug Discov Technol.
2010;
7
(4):
253-62
-
F-18 FDG PET/CT demonstration of lymphohistiocytic meningitis.
Mansouri MA,
Iagaru A.
Clin Nucl Med.
2010;
35
(8):
633-4
-
Evaluation by 18F-FDG-PET of patients with anal squamous cell carcinoma.
Iagaru A,
Kundu R, Jadvar H, Nagle D.
Hell J Nucl Med.
2009 Jan-Apr;
12
(1):
26-9
-
Combined 18F-FDG and Fluoride Approach in PET/CT Imaging: Is There a Clinical Future?
Iagaru A,
Mittra E, Goris ML, Gambhir SS.
J Nucl Med.
2009
-
Efficacy of 18F-FDG PET/CT in the evaluation of patients with recurrent cervical carcinoma.
Mittra E,
El-Maghraby T, Rodriguez CA, Quon A, McDougall IR, Gambhir SS, Iagaru A.
Eur J Nucl Med Mol Imaging.
2009;
36
(12):
1952-9
-
Incorporating cone-beam CT into the treatment planning for yttrium-90 radioembolization.
Louie JD,
Kothary N, Kuo WT, Hwang GL, Hofmann LV, Goris ML, Iagaru AH, Sze DY.
J Vasc Interv Radiol.
2009;
20
(5):
606-13
-
Novel strategy for a cocktail 18F-fluoride and 18F-FDG PET/CT scan for evaluation of malignancy: results of the pilot-phase study.
Iagaru A,
Mittra E, Yaghoubi SS, Dick DW, Quon A, Goris ML, Gambhir SS.
J Nucl Med.
2009;
50
(4):
501-5
-
Tumor Metabolic Phenotypes on 18F FDG PET.
Iagaru AH,
Gambhir SS, Goris ML.
J Nucl Med.
2009
-
(18)F-FDG-PET/CT evaluation of response to treatment in lymphoma: when is the optimal time for the first re-evaluation scan?
Iagaru A,
Wang Y, Mari C, Quon A, Goris ML, Horning S, Gambhir SS.
Hell J Nucl Med.
2008 Sep-Dec;
11
(3):
153-6
-
123I MIBG mapping with intraoperative gamma probe for recurrent neuroblastoma.
Iagaru A,
Peterson D, Quon A, Dutta S, Twist C, Daghighian F, Gambhir SS, Albanese C.
Mol Imaging Biol.
2008 Jan-Feb;
10
(1):
19-23
-
18F-FDG PET/CT evaluation of patients with ovarian carcinoma.
Iagaru AH,
Mittra ES, McDougall IR, Quon A, Gambhir SS.
Nucl Med Commun.
2008;
29
(12):
1046-51
-
90Y-ibritumomab therapy in refractory non-Hodgkin's lymphoma: observations from 111In-ibritumomab pretreatment imaging.
Iagaru A,
Gambhir SS, Goris ML.
J Nucl Med.
2008;
49
(11):
1809-12
-
F-18 FDG PET and PET/CT evaluation of response to chemotherapy in bone and soft tissue sarcomas.
Iagaru A,
Masamed R, Chawla SP, Menendez LR, Fedenko A, Conti PS.
Clin Nucl Med.
2008;
33
(1):
8-13
-
Perspectives of molecular imaging and radioimmunotherapy in lymphoma.
Iagaru A,
Goris ML, Gambhir SS.
Radiol Clin North Am.
2008;
46
(2):
243-52, viii
-
Rhabdomyosarcoma diffusely metastatic to the bone marrow: suspicious findings on 99mTc-MDP bone scintigraphy confirmed by (18)F-18 FDG PET/CT and bone marrow biopsy.
Iagaru A,
Goris ML.
Eur J Nucl Med Mol Imaging.
2008;
35
(9):
1746
-
Detection of occult medullary thyroid cancer recurrence with 2-deoxy-2-[F-18]fluoro-D-glucose-PET and PET/CT.
Iagaru A,
Masamed R, Singer PA, Conti PS.
Mol Imaging Biol.
2007 Mar-Apr;
9
(2):
72-7
-
2-Deoxy-2-[F-18]fluoro-D-glucose positron emission tomography/computed tomography in the management of melanoma.
Iagaru A,
Quon A, Johnson D, Gambhir SS, McDougall IR.
Mol Imaging Biol.
2007 Jan-Feb;
9
(1):
50-7
-
Follicular dendritic sarcoma within a focus of Castleman's disease. Serial FDG PET/CT in the follow up of recurrence with histopathologic confirmation.
Iagaru A,
Mari C, Sam Gambhir S.
Rev Esp Med Nucl.
2007 Jan-Feb;
26
(1):
40-5
-
Advances in metabolic imaging for surgical oncology.
Iagaru A,
Quon A.
Surg Oncol Clin N Am.
2007;
16
(2):
273-92
-
Breast MRI and 18F FDG PET/CT in the management of breast cancer.
Iagaru A,
Masamed R, Keesara S, Conti PS.
Ann Nucl Med.
2007;
21
(1):
33-8
-
F-18 FDG PET visualization of urinary leak after nephrostomy tube removal.
Iagaru A,
Gamie S, Segall G.
Clin Nucl Med.
2007;
32
(2):
168-9
-
F-18 FDG PET/CT demonstration of an adrenal metastasis in a patient with anaplastic thyroid cancer.
Iagaru A,
McDougall IR.
Clin Nucl Med.
2007;
32
(1):
13-5
-
F-18 FDG PET/CT in the management of thyroid cancer.
Iagaru A,
Kalinyak JE, McDougall IR.
Clin Nucl Med.
2007;
32
(9):
690-5
-
Molecular imaging can accelerate anti-angiogenic drug development and testing.
Iagaru A,
Chen X, Gambhir SS.
Nat Clin Pract Oncol.
2007;
4
(10):
556-7
-
Treatment of thyrotoxicosis.
Iagaru A,
McDougall IR.
J Nucl Med.
2007;
48
(3):
379-89
-
2-Deoxy-2-[18F]fluoro-D-glucose-positron emission tomography and positron emission tomography/computed tomography diagnosis of patients with recurrent papillary thyroid cancer.
Iagaru A,
Masamed R, Singer PA, Conti PS.
Mol Imaging Biol.
2006 Sep-Oct;
8
(5):
309-14
-
Merkel cell carcinoma: Is there a role for 2-deoxy-2-[f-18]fluoro-D-glucose-positron emission tomography/computed tomography?
Iagaru A,
Quon A, McDougall IR, Gambhir SS.
Mol Imaging Biol.
2006 Jul-Aug;
8
(4):
212-7
-
18F-FDG PET and PET/CT for detection of pulmonary metastases from musculoskeletal sarcomas.
Iagaru A,
Chawla S, Menendez L, Conti PS.
Nucl Med Commun.
2006;
27
(10):
795-802
-
Demonstration of a right inguinal hernia containing urinary bladder diverticulum on whole-body bone scan and pelvic CT.
Iagaru A,
Siegel ME.
Eur J Nucl Med Mol Imaging.
2006;
33
(2):
234
-
Demonstration of an ectopic mediastinal parathyroid adenoma on Tc-99m sestamibi myocardial perfusion scintigraphy.
Iagaru A,
Hachamovitch R, Colletti PM, Wassef H.
J Nucl Cardiol.
2006;
13
(5):
719-21
-
F-18 FDG PET evaluation of bronchial plasmacytoma with CT and MRI correlation.
Iagaru A,
Mari C, Segall G.
Clin Nucl Med.
2006;
31
(5):
279-80
-
F-18 FDG PET imaging of urinary bladder oat cell carcinoma with widespread osseous metastases.
Iagaru A,
Gamie S, Segall G.
Clin Nucl Med.
2006;
31
(8):
476-8
-
F-18 FDG PET/CT evaluation of osseous and soft tissue sarcomas.
Iagaru A,
Quon A, McDougall IR, Gambhir SS.
Clin Nucl Med.
2006;
31
(12):
754-60
-
PET/CT follow-up in nonossifying fibroma.
Iagaru A,
Henderson R.
AJR Am J Roentgenol.
2006;
187
(3):
830-2
-
FDG PET-CT demonstration of Sjogren's sialoadenitis.
Jadvar H,
Bonyadlou S, Iagaru A, Colletti PM.
Clin Nucl Med.
2005;
30
(10):
698-9
-
Failed atrial septal defect repair versus pulmonary hypertension with right ventricular failure.
Iagaru A,
Wassef H, Henderson R.
Clin Nucl Med.
2005;
30
(11):
767-8
Navigation for This Section: MIPS
Find a Researcher
Help